NTF3 and Charcot-Marie-Tooth disease type 1A: Currently, AAV1 carrying the human NT-3 cDNA scAAV1.tMCK.NTF3 is in a phase I/IIa clinical trial (NCT03520751) using bilateral intramuscular injections in CMT1A patients (Table 1, Figure 3).